Immunotherapy in ovarian, endometrial and cervical cancer: state of the art and future perspectives

The tumors of the female genital tract represent a huge health problem in Europe, Endometrial Cancer, EC, with 6.1% of cases estimated in 2012 [1] is the most common, followed by Epithelial Ovarian Cancer, EOC, and Cervical Cancer, CC; those malignancies have distinct biology and molecular features and differ from each other based on clinical behavior, nevertheless all them are associated with high mortality. Important goals have been achieved in CC prevention and treatment: the worldwide spreading of the Papanicolaou test, PAP test, has dramatically increased the rate of diagnosis for precancerous conditions/early stage tumors and the extensive HPV (Human Papillomavirus) vaccination programs are expected to produce a massive decrease in the incidence of CC in the next few years.

Source: Cancer Treatment Reviews - July 31, 2017 Category: Cancer & Oncology Authors: Jole Ventriglia, Immacolata Paciolla, Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Rosa Tambaro, Daniela Califano, Simona Losito, Giosu è Scognamiglio, Sergio Venanzio Setola, Laura Arenare, Sandro Pignata, Chiara Della Pepa Tags: Tumour Review Source Type: research